Winter 2009 Vol. 19, No. 3 - 2009 Annual Report
Download this entire issue or browse individual articles by title below.
In terms of our mission, FY 08-09 was our best year to date, MAPS gathered substantially more data than ever before, and gained more experience designing, obtaining approval for, funding, conducting, monitoring, and evaluating psychedelic psychotherapy clinical trials.
|Inside Front Cover
||Inside Back Cover